Cellular fibronectin in patients with transitional cell carcinoma of the bladder

Urological Research

Volumn 30, Issue 6, 2003, Pages 363-366

  Hegele, Axel ^a   Heidenreich, Axel ^a   Varga, Zoltan ^a   Von Knobloch, Rolf ^a   Olbert, Peter ^a   Kropf, Jürgen ^a   Hofmann, Rainer ^a  

^a Fachbereich Medizin der Universitat Marburg   (Germany)

Author keywords

Biological marker; Bladder cancer; Fibronectin; Prognostic factor

Indexed keywords

FIBRONECTIN; TUMOR MARKER;

AGED; ARTICLE; BLADDER CARCINOMA; BLOOD LEVEL; CANCER GRADING; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN; IMMUNOASSAY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINE LEVEL;

EID: 0037293584     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-002-0280-3     Document Type: Article

References (23)

1. Cassel A, Rahat MA, Lahat N, Lindenfeld N, Mecz Y, Stein A (2001) Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise. J Urol 166: 841-844
2. Castellani P, Siri A, Rosellini C, Infusini E, Borsi L, Zardi L (1986) Transformed human cells release different fibronectin variants than do normal cells. J Cell Biol 103: 1671-1677
3. Cheng CY, Martin DE, Leggett CG, Reece MC, Reese AC (1988) Fibronectin enhances healing of excised wounds in rats. Arch Dermatol 124: 221-225
4. Danisman A, Bulut K, Kukul E, Ozen I, Sevuk M (2000) Urinary fibronectin levels in patients treated with intravesical bacillus Calmette-Guerin for superficial bladder cancer. Urol Int 64: 198-201
5. Fleischmann JD, Park MC, Hassan MO (1993) Fibronectin expression on surgical specimens correlated with the response to intravesical bacillus Calmette-Guerin therapy. J Urol 149: 268-271
6. Heney NM (1992) Natural history of superficial bladder cancer. Urol Clin North Am 19: 429-433
7. Holmang S, Hedelin H, Anderstrom C, Johansson SL (1995) The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 153: 1823-1826
8. Huland H (2001) Harnblasenkarzinom. In: Hautmann RE, Huland H (eds) Urologie. Springer, Berlin Heidelberg New York, pp 204-212
9. Hynes RO, Yamada KM (1982) Fibronectins: multifunctional glycoproteins. J Cell Biol 95: 369-377
10. Kirkali G, Tuzel E, Guler C, Gezer S, Kirkali Z (2001) Significance of tissue laminin P(1) elastase and fibronectin levels in transitional cell carcinoma of the bladder. Eur Urol 39: 292-299
11. Kropf J, Gressner AM (1995) Two sensitive time-resolved fluoroimmunoassays for cellular fibronectin. Clin Chem 41: 1283-1287
12. Kropf J, Quitte E, Gressner A (1991) Time-resolved immunofluorometric assays with measurement of a europium chelate in solution: application for sensitive determination of fibronectin. Anal Biochem 197: 258-265
13. Laufer M, Kaver I, Sela B, Matzkin H (1999) Elevated urinary fibronectin levels after transurethral resection of bladder tumour: a possible role in patients failing therapy with bacillus Calmette-Guerin. BJU Int 84: 428-432
14. Malmstrom PU, Larsson A, Johansson S (1993) Urinary fibronectin in diagnosis and follow-up of patients with urinary bladder cancer. Br J Urol 72: 307-310
15. Oge O, Atsu N, Kendi S, Ozen H (2001) Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer. Int Urol Nephrol 32: 367-370
16. Ratliff TL, Hudson MA, Catalona WJ (1991) Strategy for improving therapy superficial bladder cancer. World J Urol 19: 95-98
17. Sanchez-Carbayo M, Urrutia M, Gonzalez de Buitrago JM, Navajo JA (2000) Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer. Clin Cancer Res 6: 3585-3589
18. See WA, Xu Y, Gee K, Severson C, Cohen MB, Ladehoff D (1997) Transurethral bladder tumor resection alters fibronectin expression in transitional carcinoma cell lines. J Urol 157: 1136-1143
19. Sobin LH, Wittekind C (eds) TNM classification of malignant tumors, 5th edn. Wiley & Sons, New York
20. Von Knobloch R, Hegele A, Brandt H, Olbert P, Heidenreich A, Hofmann R (2001) Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis. Int J Cancer 94: 67-72
21. Wunderlich H, Reichelt O, Zermann DH, Schubert J, Berndt A, Kosmehl H (2001) Fetal fibronectin: a new screening-marker for bladder cancer? Oncol Rep 8: 669-672
22. Zaher A, Sheridan T (2001) Tumor markers in the detection of recurrent transitional cell carcinoma of the bladder: a brief review. Acta Cytol 45: 575-581
23. Zhang GJ, Ladehoff D, Xu Y, See WA (1998) Stable overexpression of TGFbetal in a transitional carcinoma cell line: impact on fibronectin production. J Urol 160: 230-235